Skip to main content
. Author manuscript; available in PMC: 2018 Jan 2.
Published in final edited form as: Cancer Immunol Res. 2017 Oct 27;5(12):1133–1140. doi: 10.1158/2326-6066.CIR-17-0208

Figure 1.

Figure 1

Presentations of thyroid disorders after receiving immune checkpoint inhibition combination therapy or monotherapy. Thyroid disorders were divided into three groups: hypothyroidism only, thyrotoxicosis only, and thyrotoxicosis, followed by hypothyroidism. Percentage of patients with each thyroid disorder, calculated as the percentage of cases presenting with each thyroid disorder out of the total number of patients with thyroid disorders, represented for all patients (left, everyone), combination therapy (middle, combo), or monotherapy (right, mono) groups. Differences in initial presentation between the combination therapy and monotherapy groups were determined using the Fisher test; P = 0.01.